Clinical trial

Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee…

NCT00120406 · Cook Group Incorporated, Industry · Completed

Key facts

NCT number NCT00120406
Title Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery
Official title Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery
Acronym Zilver PTX
Lead sponsor Cook Group Incorporated, Industry
Collaborators William Cook Europe Industry MED Institute, Incorporated Cook Japan Incorporated
Status Completed
Study type Interventional
Conditions Peripheral Vascular Diseases
Intervention type Device, Procedure
Interventions Zilver® PTX™ Drug Eluting Vascular Stent, Angioplasty
Enrollment 474
Start date Mar 1, 2005
Primary completion Oct 1, 2009
Completion Feb 1, 2014
First posted Jul 18, 2005
Last update posted Aug 11, 2014
Countries Germany, Japan, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies